Xcout Intel
Samsung Biologics
Samsung Biologics operates as a global contract development and manufacturing organization (CDMO) providing end-to-end biopharmaceutical services to pharmaceutical and biotech companies. The company offers a range of services including cell line development, process development, analytical testing, drug substance and drug product manufacturing, and advanced modalities like bioconjugation and mRNA.
Subscribe to see Samsung Biologics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Samsung Biologics at a glance
Samsung Biologics is a biotech company headquartered in South Korea. Xcout tracks 14 named people at Samsung Biologics, including John Rim (President & CEO).
Samsung Biologics leadership
- John RimPresident & CEO
- Seung Ho RyuExecutive Vice President & CFO
- James ChoiExecutive Vice President
- Kyuho LeeExecutive Vice President & CHRO
- Kun LoExecutive Vice President, Head of EPCV Center responsible for construction and operation of new plants, and CSO (Chief Safety Officer)
- Diane BlackExecutive Vice President & CQO
8 more named people on record for Samsung Biologics, with roles, board committees and tenure — see the full roster →
Samsung Biologics competitors
A few of Samsung Biologics's closest competitors — see the full list of competitors and alternatives →
AGC Biologics is a global contract development and manufacturing organization (CDMO) that provides services for protein-based biologics and advanced therapies, including mammalian and microbial production, viral vectors, cell therapy, plasmid DNA, and mRNA. The company supports biopharmaceutical developers by offering process development, analytical formulation, cGMP manufacturing, and fill-finish services to help bring life-changing treatments to market.
Mabion SA operates as a biotechnology company and Contract Development and Manufacturing Organization (CDMO) that provides services encompassing process development, analytics, and drug substance manufacturing. The company specializes in working with biologics such as biosimilars, antibodies, antibody-drug conjugates (ADCs), and recombinant therapeutic proteins to serve biopharmaceutical clients.
Forge Biologics Holdings, LLC is the parent company of Forge Biologics, a U.S.-based contract development and manufacturing organization focused on gene therapies, particularly adeno-associated virus (AAV) programs. It provides process development, analytical services, and clinical and commercial manufacturing to biotechnology and pharmaceutical companies.
Arranta Bio is a biotechnology contract development and manufacturing organization (CDMO) focused on microbiome-based therapeutics, including live biotherapeutic products. It serves biopharmaceutical companies with process development, analytical, and manufacturing services for these products.
WuXi XDC Cayman Inc. operates as an investment holding company and a global contract research, development, and manufacturing organization (CRDMO), with operations spanning China, North America, Europe, and other international regions. The company's expertise covers the entire lifecycle, from discovery and research to development and manufacturing, of biopharmaceutical products. Specifically, it focuses on antibody-drug conjugates (ADCs), various bioconjugates, monoclonal antibody intermediates, and the crucial payload-linkers integral to bioconjugate synthesis. Founded in 2013 and headquartered in Wuxi, China, WuXi XDC Cayman Inc. is a subsidiary of WuXi Biologics (Cayman) Inc.
Concord Biotech Limited is a leading R&D-based biopharmaceutical company headquartered in Ahmedabad, India. Founded in 2000, it specializes in manufacturing Active Pharmaceutical Ingredients (APIs) and high-quality biotechnology products.
Get Samsung Biologics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Samsung Biologics in Xcout Intel
- 14 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access